China Widens MAH Scheme To Medtech As Consumables Face Price Cuts
Executive Summary
China is quickly expanding its marketing authorization holder scheme from drugs to devices. It is also vowing to reduce medical costs by using more low-cost, domestic consumables, which will have a significant impact on companies.